A test used in the diagnosis of myasthenia gravis (MG). A short-acting anticholinesterase drug, such as edrophonium chloride or neostigmine, is injected, and the patient is observed for improved muscular strength. The patient is also observed after an injection of a placebo (e.g., saline). Improvement with the active drug, but not the placebo, is a strong indication of MG.